Treatment of chronic idiopathic urticaria with topical preparations: controlled study of oxatomide gel versus dechlorpheniramine cream.
A controlled and completely randomized study was carried out with the aim of assessing the efficacy and safety of oxatomide gel in comparison with another preparation for topical use, dechlorpheniramine. Twenty-seven patients (sixteen F, eleven M) aged between 21 and 72 years (mean age 39) suffering from chronic idiopathic urticaria were treated for 15 days with oxatomide gel at 5% or dechlorpheniramine cream at 1%; 15 days of follow-up without therapy were then observed. Both the treatments allowed significant control of cutaneous symptoms. In particular, in the group treated with oxatomide there was a more marked reduction in itching and in the number of weals (p less than 0.01 between times), and in the dechlorpheniramine group in the severity of erythema (p less than 0.01 between times). During the follow-up period, a distinct flare-up of symptoms was observed only in the dechlorpheniramine group. Acceptability and safety, both clinical and biological, were good for both products.
Locci
F
F
Medical Pathology II, Cagliari Polyclinic, Italy.
Del Giacco
G S
GS
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D004890:Erythema / Q000188:drug therapy; D005260:Female; D005782:Gels; D006634:Histamine H1 Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010632:Pheniramine / Q000008:administration & dosage* / Q000009:adverse effects; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects; D011537:Pruritus / Q000188:drug therapy; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
D005782:Gels; D006634:Histamine H1 Antagonists; D009824:Ointments; D010879:Piperazines; D010632:Pheniramine; C015408:oxatomide